This came because its "β2 effect" was not quite as selective as might be hoped. β1 receptors appeared to also be stimulated in some patients, causing cardiac and other CNS side effects.
This occurred because the drug's β2 effect was not as selective as hoped for. It also activated β1 receptors in some patients, leading to adverse effects on the cardiovascular and central nervous systems.